T1	Participants 285 429	5143 healthy adults received 10 Î¼g hepatitis B vaccine at 0, 1 and 3 months(group A), 0, 1 and 6 months(group B), or 0, 1 and 12 months(group C)
T2	Participants 680 751	2438 healthy adults finished the full vaccination program and follow-up
